...
首页> 外文期刊>Breast Cancer Research and Treatment >BRCA1/2 mutation testing in breast cancer patients: a prospective study of the long-term psychological impact of approach during adjuvant radiotherapy
【24h】

BRCA1/2 mutation testing in breast cancer patients: a prospective study of the long-term psychological impact of approach during adjuvant radiotherapy

机译:乳腺癌患者的BRCA1 / 2突变测试:辅助放疗期间方法对长期心理影响的前瞻性研究

获取原文
获取原文并翻译 | 示例

摘要

This study assessed psychological distress during the first year after diagnosis in breast cancer patients approached for genetic counseling at the start of adjuvant radiotherapy and identified those vulnerable to long-term high distress. Of the approached patients some chose to receive a DNA test result (n = 58), some were approached but did not fulfill criteria for referral (n = 118) and some declined counseling and/or testing (n = 44). The comparative group consisted of patients not eligible for genetic counseling (n = 182) and was therefore not approached. Patients actively approached for genetic counseling showed no more long-term distress than patients not eligible for such counseling. There were no differences between the subgroups of approached patients. Predictors for long-term high distress or an increase in distress over time were pre-existing high distress and a low quality of life, having children, and having no family members with breast cancer. It is concluded that breast cancer patients can be systematically screened and approached for genetic counseling during adjuvant radiotherapy without imposing extra psychological burden. Patients vulnerable to long-term high distress already displayed high distress shortly after diagnosis with no influence of their medical treatment on their level of distress at long-term.
机译:这项研究评估了乳腺癌患者在诊断后第一年的心理困扰,该患者在辅助放疗开始时就接受了遗传咨询,并确定了那些易患长期高度困扰的人群。在接诊的患者中,有些选择接受DNA检测结果(n = 58),有些接受了治疗,但未达到转诊标准(n = 118),有些拒绝了咨询和/或检测(n = 44)。比较组由不符合遗传咨询条件的患者组成(n = 182),因此未接受治疗。积极寻求遗传咨询的患者与没有资格接受遗传咨询的患者相比,长期困扰不多。接触患者的亚组之间没有差异。长期的高困扰或随着时间增加的困扰的预测因素是预先存在的高困扰和低质量的生活,有孩子并且没有家庭成员患有乳腺癌。结论是,可以在辅助放疗期间系统地筛查乳腺癌患者并寻求遗传咨询,而不会造成额外的心理负担。长期处于高危状态的患者在诊断后不久就已经表现出高危状态,而其药物治疗对其长期的危重程度没有影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号